XNYS
HUM
Market cap52bUSD
Oct 08, Last price
387.12USD
1D
-2.37%
1Q
-1.30%
Jan 2017
89.74%
Name
Humana Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Humana Inc., along with its various subsidiaries, functions as a prominent health and well-being organization exclusively within the United States. Its operations are strategically divided into three key divisions: Retail, Group and Specialty, and Healthcare Services. The company provides a range of medical and supplemental benefit plans directly to individual consumers. Humana actively participates in government-sponsored health initiatives, holding contracts with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LINET) prescription drug plan. Additionally, it partners with numerous states to deliver benefits under Medicaid, dual eligible programs, and long-term support services. Beyond this, it extends commercial fully insured medical and specialized health coverage, encompassing dental, vision, and other ancillary health benefits. Humana also furnishes administrative services only (ASO) products to both individuals and employer groups, and supports military personnel through programs like the TRICARE T2017 East Region contract. Furthermore, its service portfolio includes pharmacy solutions, provider support, and comprehensive home-based care (such as home health), catering to both its health plan enrollees and external clients. As of December 31, 2021, Humana's member base comprised roughly 17 million individuals enrolled in medical benefit plans, alongside approximately 5 million participating in specialty offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
Related entities
Subsidiaries (8)
Arcadian Health Plan, Inc.
CHA HMO, Inc.
HUMANA BENEFIT PLAN OF ILLINOIS, INC.
Humana Health Plan, Inc.
HUMANA INSURANCE COMPANY
MANAGED CARE INDEMNITY, INC.
EMPHESYS INSURANCE COMPANY
HUMANA HEALTH BENEFIT PLAN OF LOUISIANA, INC.
Key people
Independent Chairman of the Board · since 2014
James Rechtin
President, Chief Executive Officer, Director · since 2024
Celeste Mellet
Chief Financial Officer · since 2025
David Dintenfass
President - Enterprise Growth · since 2024
Aaron Martin
President - Medicare Advantage · since 2026
George Renaudin
President - Insurance · since 2024
Sanjay Shetty
President - CenterWell · since 2023
Michelle O'Hara
Chief Human Resources Officer · since 2025
John- Paul Felter
Senior Vice President, Chief Accounting Officer, Controller · since 2022
Japan Mehta
Chief Information Officer · since 2025
Vishal Agrawal
Chief Strategy and Corporate Development Officer · since 2018
Joseph Ventura
Chief Legal Officer · since 2019
Raquel Bono
Independent Director · since 2020
Independent Director · since 2003
Independent Director · since 2022
Independent Director · since 2020
Independent Director · since 2020
Karen Katz
Independent Director · since 2019
Independent Director · since 2021
Independent Director · since 2021
Legal address
C/O THE CORPORATION TRUST COMPANY
CORPORATION TRUST CENTER
1209 ORANGE ST
WILMINGTON, DE 19801
US
CORPORATION TRUST CENTER
1209 ORANGE ST
WILMINGTON, DE 19801
US
Headquarters
500 West Main Street
Louisville, KY 40202
US
Louisville, KY 40202
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||